Clinical Evidence and Statistics A clinical trial 6 involving topical GHK-Cu in human volunteers (n = 40, age 4065) showed significant reductions in wrinkle volume (~31.6 %) and depth (~32.8 %) compared to vehicle control over 8 weeks
Xie et al., 2016), which induces an adaptive immune response, via cytokines such as interleukin (IL)-1, IL-6, IL-12, interferon (IFN)-, IFN-, and tumor necrosis factor-alpha (TNF-) (Xie et al., 2016)
Tirzepatide effects often appear within the first 1-2 weeks
Typically, lyophilized peptide powders are stored at low temperatures (around 20 C), protected from light and moisture, and shielded from repeated freeze-thaw cycles to maintain integrity
After one week without adverse effects, many progress to 0.5 mg daily